Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome

Arthritis and Rheumatism

Volumn 56, Issue 4, 2007, Pages 1134-1144

  Daridon, Capucine ^a   Devauchelle, Valérie ^a   Hutin, Pascal ^a   Le Berre, Rozenn ^a   Martins Carvalho, Christine ^a   Bendaoud, Boutahar ^a   Dueymes, Maryvonne ^a   Saraux, Alain ^a   Youinou, Pierre ^a   Pers, Jacques Olivier ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; B LYMPHOCYTE STIMULATOR RECEPTOR 3; CELL PROTEIN; PROTEIN BCMA; PROTEIN TACI; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; B LYMPHOCYTE; CELL CULTURE; CELL SURVIVAL; CLINICAL ARTICLE; CULTURE MEDIUM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND; SELF STIMULATION; SJOEGREN SYNDROME; T LYMPHOCYTE;

ADULT; AGED; B-CELL ACTIVATING FACTOR; B-CELL MATURATION ANTIGEN; B-LYMPHOCYTES; BIOLOGICAL MARKERS; COCULTURE TECHNIQUES; EPITHELIAL CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALIVARY GLANDS; SJOGREN'S SYNDROME; T-LYMPHOCYTES; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; U937 CELLS;

EID: 34247230559     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22458     Document Type: Article

References (50)

1. Moutsopoulos HM. Sjögren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994;72:162-5.
2. Moutsopoulos HM, Webber BL, Vlagopoulos TP, Chused TM, Decker JL. Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med 1979;66:733-6.
3. Tzioufas AG, Youinou P, Moutsopoulos HM. Sjögren's syndrome. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editors. Oxford textbook of rheumatology. 2nd ed. Oxford: Oxford University Press; 1998. p. 1301-17.
4. Radiar L, Kleiner DE, Fox PC, Pillemer SR. Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers. Arthritis Rheum 2002;47:520-4.
5. Dorner T, Lipsky PE. Abnormalities of B-cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome. Arthritis Res 2002;4:360-71.
6. Youinou P, Daridon C, Steinfeld S, Pers JO. A case for B cells in the pathogenesis of Sjögren's syndrome. Trends Immunol. In press.
7. Youinou P, Devauchelle V, Hutin P, Le Berre R, Saraux A, Pers JO. A conspicuous role for B cells in Sjögren's syndrome [review]. Clin Rev Allergy Immunol. In press.
8. Martin F, Kearney JF. Marginal-zone B cells [review]. Nat Rev Immunol 2002;2:233-5.
9. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B-cell subsets of human tonsil. J Exp Med 1994;180:329-39.
10. Do RK, Hatada E, Lee H, Tourigny MR, Hilbert D, Chen-Kiang S. Attenuation of apoptosis underlies B-lymphocyte stimulator enhancement of humoral immune response. J Exp Med 2000;192:953-64.
11. Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F, et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004;20:785-98.
12. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, et al. Association of BAFF/BLyS overexpression and altered B-cell differentiation with Sjögren's syndrome. J Clin Invest 2002;109:59-68.
13. Pers JO, Daridon C, Devauchelle V, Jousse S, Saraux A, Jamin C, et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 2005;1050:34-9.
14. Pers JO, d'Arbonneau F, Devauchelle-Pensec V, Saraux A, Pennec YL, Youinou P. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome? Arthritis Rheum 2005;52:2411-4.
15. Lavie F, Miceli-Richard C, Quillard J, Roux S, Leclerc P, Mariette X. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome. J Pathol 2004;202:496-502.
16. Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, Migone TS, et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 2001;97:198-204.
17. Craxton A, Magaletti D, Ryan EJ, Clark EA. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 2003;101:4464-71.
18. Gorelik L, Gilbride K, Dobles M, Kalled SL, Zondman D, Scott ML. Normal B cell homeostasis requires B-cell activation factor production by radiation-resistant cells. J Exp Med 2003;198:937-47.
19. Scapini P, Nardelli B, Nadali G, Calzetti F, Pizzolo G, Montecucco C, et al. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J Exp Med 2003;197:297-302.
20. Okata J, Zvaifler NJ, Nishio M, Boyle DL, Kalled SL, Carson DA, et al. Synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J Immunol 2005;174:864-70.
21. Krumbholz M, Theil D, Derfuss T, Rosenwald A, Schrader F, Monoranu CM, et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 2005;201:195-200.
22. Schneider P, Mackay F, Steiner V, Hofmann K, Bodmer JL, Holler N, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999;189:1747-56.
23. Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, Stenou V, et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 2004;103:679-88.
24. Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, et al. BLyS: member of the tumor necrosis factor family and B-lymphocyte stimulator. Science 1999;285:260-3.
25. Novak AJ, Bram RJ, Kay NE, Jelinek DF. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood 2002;100:2973-9.
26. Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2002;2:465-75.
27. Daridon C, Pers JO, Devauchelle V, Martins-Carvalho C, Hutin P, Pennec YL, et al. Identification of transitional type II B cells in salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2006;54:2280-8.
28. Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren's syndrome. J Clin Immunol 2005;25:187-99.
29. Wu Y, Bressette D, Carrell JA, Kaufman T, Feng P, Taylor K, et al. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J Biol Chem 2000;275:35478-85.
30. Shu HB, Johnson H. B-cell maturation protein is a receptor for the TNF family member TALL-1. Proc Natl Acad Sci U S A 2000;97:9156-61.
31. Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001;293:2108-11.
32. Von Bulow GU, Bram RJ. NF-AT activation induced by a CAML-interacting member of the TNF receptor superfamily. Science 1997;278:138-41.
33. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
34. Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome: assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984;27:147-56.
35. Devauchelle V, Morvan J, Pennec Y, Pers JO, Jamin C, Jousse S, et al. Rituximab (anti-CD20) in the treatment of primary Sjögren's syndrome: results of an open-label study [abstract]. Ann Rheum Dis 2005;64 Suppl III:iii309.
36. Devauchelle V, Pennec Y, Morvan J, Pers JO, Daridon C, Jousse S, et al. Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum. In press.
37. Dimitriou ID, Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN. Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells. Eur J Oral Sci 2002;110:21-30.
38. Hillion S, Saraux A, Youinou P, Jamin C. Expression of RAGs in peripheral B cells outside germinal centers is associated with the expression of CD5. J Immunol 2005;174:5553-61.
39. D'Arbonneau F, Pers JO, Devauchelle V, Pennec Y, Saraux A, Youinou P. BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome. Arthritis Rheum 2006;54:115-26.
40. Szodoray P, Jellestad S, Teague MO, Jonsson R. Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjögren's syndrome. Lab Invest 2003;83:357-65.
41. Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, Scott ML, et al. B-cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 2004;173:807-17.
42. Sasaki Y, Casola S, Kutok JL, Rajewsky K, Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B-cell physiology. J Immunol 2004;173:2245-52.
43. Hsu BL, Harless SM, Lindsley RC, Hilbert DM, Cancro MP. BLyS enables survival of transitional and mature B cells through distinct mediators. J Immunol 2002;168:5993-6.
44. Schneider P, Takatsuka H, Wilson A, Mackay F, Tardivel A, Lens S, et al. Maturation of marginal zone and follicular B cells requires B-cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J Exp Med 2001;194:1691-7.
45. Smith SH, Cancro MP. Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors. J Immunol 2003;170:5820-3.
46. Gorelik L, Cutler AH, Thill G, Miklasz SD, Shea DE, Ambrose C, et al. BAFF regulates CD21/35 and CD23 expression independent of its B-cell survival function. J Immunol 2004;172:762-6.
47. Zhang X, Park CS, Yoon SO, Li L, Hsu YM, Ambrose C, et al. BAFF supports human B-cell differentiation in the lymphoid follicles through distinct receptors. Int Immunol 2005;17:779-88.
48. Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, et al. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2002;46:2160-71.
49. O'Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, Ahonen C, et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 2004;199:91-8.
50. St.Clair EW, Tedder TF. New prospects for autoimmune disease therapy: B cells on deathwatch [editorial]. Arthritis Rheum 2006;54:1-9.